Page last updated: 2024-10-21

3-aminobenzamide and Sepsis

3-aminobenzamide has been researched along with Sepsis in 2 studies

Sepsis: Systemic inflammatory response syndrome with a proven or suspected infectious etiology. When sepsis is associated with organ dysfunction distant from the site of infection, it is called severe sepsis. When sepsis is accompanied by HYPOTENSION despite adequate fluid infusion, it is called SEPTIC SHOCK.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zhang, L1
Yao, J1
Wang, X1
Li, H1
Liu, T1
Zhao, W1
Murakami, K1
Enkhbaatar, P1
Shimoda, K1
Cox, RA1
Burke, AS1
Hawkins, HK1
Traber, LD1
Schmalstieg, FC1
Salzman, AL1
Mabley, JG1
Komjáti, K1
Pacher, P1
Zsengellér, Z1
Szabó, C1
Traber, DL1

Other Studies

2 other studies available for 3-aminobenzamide and Sepsis

ArticleYear
Poly (ADP-ribose) synthetase inhibitor has a heart protective effect in a rat model of experimental sepsis.
    International journal of clinical and experimental pathology, 2015, Volume: 8, Issue:9

    Topics: Animals; Apoptosis; Benzamides; Disease Models, Animal; Heart; Immunohistochemistry; Male; Microscop

2015
Inhibition of poly (ADP-ribose) polymerase attenuates acute lung injury in an ovine model of sepsis.
    Shock (Augusta, Ga.), 2004, Volume: 21, Issue:2

    Topics: Animals; Antithrombins; DNA Damage; Enzyme Inhibitors; Female; Hematocrit; Hemoglobins; Immunohistoc

2004